These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2394355)

  • 1. [Effect of pyridoxal-5-phosphate-modified polyhemoglobin on mammals' erythrocyte aggregation].
    Smirnov IV; Groznaia TG; Khachatur'ian AA
    Gematol Transfuziol; 1990 May; 35(5):14-6. PubMed ID: 2394355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pyridoxalated polyhemoglobin and stroma-free hemoglobin on ADP-induced platelet aggregation.
    Lalla FR; Ning J; Chang TM
    Biomater Artif Cells Artif Organs; 1989; 17(3):363-9. PubMed ID: 2819260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of polyhemoglobin composition on erythrocyte aggregation and circulation time in the vascular bed].
    Litvinenko IuA; Azhigirova MA; Viazova EP; Shuvalova AL; Sokolov AV; Kolonina IR
    Biull Eksp Biol Med; 1993 Jan; 115(1):27-9. PubMed ID: 8054567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the effectiveness of artificial oxygen carrier on the hemoglobin base in blood loss replacement in dogs].
    Litvinenko IuA; Kolonina IR; Sokolov AV; Gorbunova NA
    Gematol Transfuziol; 1991 Aug; 36(8):16-8. PubMed ID: 1752403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo assessment of pyridoxylated crosslinked polyhemoglobin as an artificial red cell substitute in rats.
    Keipert PE; Chang TM
    Trans Am Soc Artif Intern Organs; 1983; 29():329-33. PubMed ID: 6673249
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodynamics and oxygen transport after partial and total blood exchange with pyridoxalated polyhemoglobin in dogs.
    Hobbhahn J; Vogel H; Kothe N; Brendel W; Peter K; Jesch F
    Acta Anaesthesiol Scand; 1985 Jul; 29(5):537-43. PubMed ID: 4036540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemoglobin-based blood substitutes and infection.
    Langermans JA; Bleeker WK
    Lancet; 1995 Apr; 345(8953):863-4. PubMed ID: 7898253
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety studies of modified hemoglobin as an oxygen-carrying blood substitute.
    Chang TM
    Hematol Pathol; 1993; 7(1):49-55. PubMed ID: 8468266
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of modified hemoglobin solutions on the isolated rabbit heart.
    Biessels PT; Hak JB; Bleeker WK; van Beek JH; Bakker JC
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):693-6. PubMed ID: 1391498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects after partial exchange transfusion with pyridoxylated polyhemoglobin in chimpanzees.
    Lenz G; Junger H; van den Ende R; Brotman B; Prince AM
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(4):709-18. PubMed ID: 1810405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemoglobin-based blood substitutes and sepsis.
    Griffiths E; Cortes A; Gilbert N; Stevenson P; MacDonald S; Pepper D
    Lancet; 1995 Jan; 345(8943):158-60. PubMed ID: 7823671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell substitutes: microencapsulated hemoglobin and cross-linked hemoglobin including pyridoxylated polyhemoglobin & conjugated hemoglobin.
    Chang TM
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):11-29. PubMed ID: 3052638
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological and systemic effects of transfusions in rats using pyridoxylated hemoglobin and polyhemoglobin from homologous and heterogeneous sources.
    Chang TM; Varma R
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):205-15. PubMed ID: 3179465
    [No Abstract]   [Full Text] [Related]  

  • 14. [Animal experiment studies on hemodynamics following partial and total blood exchange with a pyridoxalated polyhemoglobin solution].
    Hobbhahn J; Jesch F; Conzen P; Brendel W; Peter K
    Anaesthesist; 1985 Aug; 34(8):396-401. PubMed ID: 3931496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyridoxalated heterogenous and homologous polyhemoglobin and hemoglobin: systemic effects of replacement transfusion in rats previously received immunizing doses.
    Chang TM; Varma R
    Biomater Artif Cells Artif Organs; 1987; 15(2):443-51. PubMed ID: 3447650
    [No Abstract]   [Full Text] [Related]  

  • 16. Acellular and cellular hemoglobin solutions as vasoconstrictive factor.
    Nakai K; Matsuda N; Amano M; Ohta T; Tokuyama S; Akama K; Kawakami Y; Tsuchida E; Sekiguchi S
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):559-64. PubMed ID: 7527722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, physico-chemical and biological properties of crosslinked modified hemoglobin.
    Kuznetsova NP; Gudkin LR; Mishaeva RN; Stragovich LM; Bistrova IM; Selivanov EA
    Artif Cells Blood Substit Immobil Biotechnol; 1998 Mar; 26(2):213-22. PubMed ID: 9564439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and in vitro characteristics of a blood substitute based on pyridoxylated polyhemoglobin.
    Keipert PE; Chang TM
    Appl Biochem Biotechnol; 1984; 10():133-41. PubMed ID: 6524922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polyhemoglobin-based model of an artificial oxygen carrier with functional properties similar to blood].
    Khachatur'ian AA; Shlimak VM; Azhigirova MA; Viazova EP; Zeĭnalov AM
    Biull Eksp Biol Med; 1981 Mar; 91(3):311-3. PubMed ID: 7248504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The transhemenation process of bovine and human hemoglobin polymers under conditions simulating the situation in the circulatory bed].
    Smirnov IV; Khachatur'ian AA
    Biull Eksp Biol Med; 1991 Nov; 112(11):500-1. PubMed ID: 1810487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.